1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Haematological Malignancy: new trials by email Literature Review of Haematological Malignancy trials Research Report on Haematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote Monitoring of Cancer Patients With Suspected Covid-19 Patient Status Engine - COVID, Oncology | Phase 1 | Unknown | The Christie NHS Foundation Trust | 30 | 2020-10-12 | 2021-02-11 |
| Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies CCS1477, Pomalidomide, Dexamethasone - Haematological Malignancy, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Recruiting | CellCentric Ltd. | 250 | 2019-08-09 | 2026-06-24 |
Hematologic Neoplasms (2) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Peripheral (1) · Multiple Myeloma (1) · Neoplasms (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms by Site (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Myeloid (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1)
Azacitidine (1) · Bortezomib (1) · CCS1477 (1) · Dexamethasone (1) · Lenalidomide (1) · daratumumab (1) · ixazomib (1) · pomalidomide (1) · venetoclax (1)
CellCentric Ltd. (1) · The Christie NHS Foundation Trust (1)
United Kingdom (2) · France (1) · Spain (1) · Sweden (1) · United States (1)
John Radford (1) · Tim Somervaille (1)